Browse the evidence

Major calorie restriction via low-energy liquid diets can reverse Type 2 Diabetes by reducing ectopic fat in the liver and pancreas, restoring beta-cell function.

For some motivated individuals, Type 2 Diabetes can be reversed through significant weight loss, specifically by reducing fat stored in the liver and pancreas. This often involves short-term use of low-energy liquid diets under medical supervision. Consult your doctor to see if this approach is suitable for you.

Randomized clinical trials demonstrate that dietary interventions (specifically low-carbohydrate or high-fiber diets) and physical activity significantly improve insulin sensitivity in obese individuals.

To improve insulin sensitivity, prioritize limiting carbohydrate intake and increasing dietary fiber through whole grains, vegetables, and legumes. Combine this with regular physical activity, as these are the most prominent intervention strategies found in recent clinical trials for obesity and insulin resistance.

Pharmacologic weight loss medications, particularly FDA-approved anti-obesity agents (GLP-1 agonists, phentermine, lorcaserin), are safe and effective for inducing weight loss in patients with cirrhosis without worsening liver disease severity (MELD score).

For patients with cirrhosis and obesity, current guidelines limit treatment to lifestyle changes due to safety concerns. However, this study indicates that FDA-approved weight-loss medications (like GLP-1 agonists) and other weight-loss associated drugs (like metformin) can be used safely in patients with advanced liver disease. These medications resulted in significant weight loss (average 7.22 kg for FDA-approved drugs) without worsening liver disease markers (MELD score) or increasing hospitalizations. Patients should discuss these options with their hepatologist, as individual safety profiles vary, and some medications may require dose adjustments or avoidance in severe hepatic impairment.

High-intensity interval training (HIIT) is a viable exercise modality for patients with Type 1 Diabetes, offering benefits such as improved quality of life and lower rates of hypoglycemia compared to moderate aerobic exercise.

Consider trying High-Intensity Interval Training (HIIT) if you struggle with time or fear of low blood sugar during exercise. Studies show it can improve quality of life and has lower hypoglycemia rates than moderate aerobic exercise. Start with a progressive program and monitor your glucose.

High-intensity physical training, including both cardiovascular and strength modalities, is an effective and increasingly popular intervention for the rehabilitation and treatment of various chronic diseases and disorders.

If you have a chronic condition like heart disease, diabetes, or chronic pain, high-intensity training (both cardio and strength) is a recognized part of modern rehabilitation. While you should consult your doctor to ensure it is safe for your specific case, this approach is gaining traction as a standard treatment option rather than being avoided.

Dietary advice is a crucial component of cardiovascular disease management, and pharmacological treatment alone (e.g., statins) is inadequate for optimal patient outcomes.

Do not rely solely on medication for heart health. Even if you are taking statins or other drugs, your diet remains a critical factor in managing cardiovascular risk. Focus on overall nutritional quality rather than assuming medication covers all bases.

Post-weigh-in rehydration should involve consuming 125-150% of lost body mass in fluids containing specific electrolytes (1700mg Na, 800mg K, 2300mg Cl, 13g CHO per liter) to maximize absorption and retention.

After weigh-in, drink fluids containing sodium, potassium, chloride, and carbs (like a sports drink or ORS). Drink 125-150% of the weight you lost. Start with 750-1000mL right away, wait 30 minutes, then eat a small, digestible meal with 50-100g carbs. Continue drinking at 1-1.5 liters per hour.

Addressing overweight and obesity is a primary strategy for reducing the risk of CHD development and progression.

Maintain a healthy weight through a balanced diet and regular moderate exercise. In regions with specific dietary habits (like high carbohydrate intake), focusing on increasing vegetable and fruit consumption and reducing refined carbs is key to lowering heart disease risk.

Long-term (4.5 years) physiotherapist-provided physical activity on prescription (PaP) significantly increases exercise capacity (EC) in physically inactive patients with metabolic risk factors, demonstrating that sustained behavioral change is achievable in primary care.

If you are inactive and have metabolic risks, standard short-term advice may not be enough. A long-term, individually tailored plan with regular check-ins from a physiotherapist can significantly improve your exercise capacity over several years, which is linked to better longevity. The key is sustained, personalized support, not just a one-time prescription.

Nutritional guidance provided by a registered dietitian significantly improves dyslipidemia markers (total and LDL cholesterol) in patients with moderate obesity, even when BMI changes are not statistically significant.

If you have obesity, ask for a referral to a registered dietitian. Even if your weight doesn't drop significantly in the first few months, this guidance can significantly improve your cholesterol levels and reduce cardiovascular risk. Focus on the metabolic benefits, not just the number on the scale.

Weight loss interventions, including lifestyle changes and bariatric surgery, reduce blood pressure, glomerular hyperfiltration, and proteinuria in obese patients with CKD.

If you are overweight and have diabetes, losing weight through diet and exercise can cut your risk of developing kidney disease by 30%. This benefit comes from lowering your blood pressure and reducing the strain on your kidneys. Talk to your doctor about a structured weight loss program.

Weight loss of 10-15% in patients with obesity and Type 2 Diabetes has disease-modifying effects, including improved glycaemic control, reduced need for medication, and potential disease remission.

For patients with obesity and Type 2 Diabetes, aim for a weight loss of 10-15% of body weight. This level of loss is not just for appearance but can modify the disease course, potentially leading to remission and reduced medication needs. This is particularly important for those with higher BMI.

A Nurse Practitioner-supervised medical weight loss program combining a 1500-1800 calorie diet and 30 minutes of aerobic activity 3-4 times per week significantly reduces BMI in obese adults over a three-month period.

To lose weight, aim for 1500-1800 calories daily and do 30 minutes of moderate aerobic exercise (like brisk walking) 3-4 times a week. Crucially, stay in a structured program with regular check-ins (e.g., weekly) for at least 3 months, as consistency is the strongest driver of success.

Increasing the frequency of clinical visits in obesity management (specifically ≥11 visits/year) significantly increases the likelihood of achieving clinically meaningful weight loss (≥5% body weight).

If you are managing obesity, aim for at least 11 clinic visits per year. This frequency is associated with a much higher chance (over 60%) of losing at least 5% of your body weight compared to fewer visits. Consistent check-ins help maintain motivation and adjust your lifestyle plan effectively.

Structured, ongoing nutritional counseling and education significantly increase weight management nutrition knowledge scores compared to baseline or no counseling.

If you are trying to manage your weight, seek out professional nutritional counseling rather than relying solely on self-education. The study shows that ongoing interaction with a dietitian significantly improves your understanding of weight management principles, which is a key component of long-term success.

Combining aerobic and resistance exercise produces greater cardiovascular benefits in Type 2 Diabetes patients than performing either modality in isolation.

If you have Type 2 Diabetes, don't just pick one type of exercise. Do both. Aim for at least 150 minutes of moderate cardio (like brisk walking) spread over 3-5 days, and add 2-3 days of strength training (like weight lifting or bodyweight exercises) on different days. Doing both together gives you better heart protection than doing just one.

Time-restricted eating (TRE) with an 8-hour window and ad libitum intake reduces body weight, fat mass, and visceral fat in overweight adults with a baseline eating window ≥14 hours, primarily through reduced eating occasions rather than explicit caloric restriction.

If you currently eat over 14 hours a day, try compressing your eating into an 8-hour window (e.g., 10 am to 6 pm) without changing what or how much you eat. This natural reduction in eating frequency may lead to modest weight and fat loss over 12 weeks.

Modest weight loss (mean 8% of initial body weight) achieved through energy-restricted diets with or without exercise significantly improves arterial stiffness, as measured by carotid-femoral and brachial-ankle pulse wave velocity.

You do not need to achieve massive weight loss to improve your arterial health. This analysis shows that losing about 8% of your body weight through diet and lifestyle changes significantly improves arterial stiffness (measured by PWV). Focus on achieving this modest, sustainable reduction rather than aiming for extreme weight loss.

Behavioral interventions (diet, exercise, or lifestyle) and pharmacologic interventions (orlistat or metformin) combined with behavioral strategies both result in clinically significant weight loss and reduced incidence of type 2 diabetes in overweight and obese adults.

For adults with overweight or obesity, combining dietary changes with increased physical activity is effective for weight loss. Adding orlistat or metformin to this behavioral plan can enhance weight loss and reduce the risk of type 2 diabetes, particularly in those with prediabetes. While exercise alone may not be sufficient for significant weight loss, combining it with diet is beneficial. Be aware that orlistat can cause mild gastrointestinal side effects, which often subside.

Modest weight loss (≥5% and ≥10% of baseline body weight) significantly reduces the incidence of type 2 diabetes in prediabetic populations.

Losing just 5-10% of your body weight can significantly lower your risk of developing type 2 diabetes if you are currently prediabetic. This benefit is achieved through behavioral changes like diet and exercise, and can be enhanced with medications like orlistat or metformin.

Tirzepatide, a dual GIP and GLP-1 receptor agonist, produces substantial, clinically meaningful, and sustained weight reduction in adults with obesity (BMI ≥30 or ≥27 with comorbidities) when used as an adjunct to lifestyle intervention, demonstrating superior efficacy compared to selective GLP-1 receptor agonists.

If you have obesity (BMI ≥30, or ≥27 with health issues like high blood pressure or sleep apnea), tirzepatide is a once-weekly injection that works by mimicking gut hormones (GIP and GLP-1) to help you lose weight. It is used alongside a reduced-calorie diet and exercise. The dose starts low (2.5 mg) and increases every 4 weeks to minimize stomach issues, reaching up to 15 mg. Clinical trials are designed to show it causes more weight loss than older drugs like semaglutide.

Combination anti-obesity medications (AOMs) are more effective than monotherapy for treating weight regain after bariatric surgery, with patients prescribed three or more AOMs losing significantly more weight than those on one.

If you have regained weight after bariatric surgery, taking just one weight-loss medication may not be enough. This study suggests that using a combination of anti-obesity medications, along with lifestyle changes, leads to significantly greater weight loss than using a single medication. Talk to your doctor about whether a combination approach is right for you, keeping in mind that access and cost can be barriers.

A 4-week low-carbohydrate diet (25% carbs, 45% protein, 30% fat) significantly reduces body weight, BMI, and body fat in obese adults while shifting gut microbiota composition by decreasing Firmicutes and increasing Bacteroidetes.

Adopt a low-carbohydrate diet for 4 weeks, aiming for 25% carbs, 45% protein, and 30% fat. Calculate your daily calories based on your ideal body weight (ideal weight in kg multiplied by 20-25, then by 0.75). Focus on high-protein foods, non-starchy vegetables, and use meal replacements if needed to stay on track. Drink at least 1.8 liters of water daily. This approach has been shown to significantly reduce body weight, BMI, and body fat, while improving gut microbiota diversity.

A medically supervised weight management program combining complete meal replacement (82 kcal/g) with behavioral counseling produces a statistically significant average 5.8% weight loss at 5 years, with 35.2% of participants achieving ≥10% weight loss.

To achieve significant long-term weight loss, you need a structured program that combines a strict initial diet (like meal replacements) with ongoing behavioral support. This study shows that losing 5-10% of your body weight over 5 years is possible without surgery or drugs if you commit to weekly counseling and gradual transition to regular food. The key is not just the diet, but the long-term behavioral support and accountability.